Results 131 to 140 of about 12,011 (181)
Some of the next articles are maybe not open access.

Lipopolysaccharide chemotypes of Burkholderia cepacia

Journal of Medical Microbiology, 1999
Burkholderia cepacia is an important pathogen in patients with cystic fibrosis (CF) and much is now known of its epidemiology. In contrast, its virulence mechanisms are poorly understood. The lipopolysaccharide (LPS) of B. cepacia, a well-recognised virulence factor of other gram-negative bacteria, is known to be strongly endotoxic in vitro. The aim of
Elwyn, Evans   +2 more
openaire   +2 more sources

Advances in Burkholderia cepacia complex

Paediatric Respiratory Reviews, 2002
Burkholderia cepacia is an important opportunistic pathogen in certain compromised hosts, particularly those with either cystic fibrosis (CF) or chronic granulomatous disease. The "family" of bacteria known as B. cepacia is highly heterogeneous and is composed of at least nine discrete species or genomovars, constituting the B.
openaire   +2 more sources

The multifarious, multireplicon Burkholderia cepacia complex

Nature Reviews Microbiology, 2005
The Burkholderia cepacia complex (Bcc) is a collection of genetically distinct but phenotypically similar bacteria that are divided into at least nine species. Bcc bacteria are found throughout the environment, where they can have both beneficial and detrimental effects on plants and some members can also degrade natural and man-made pollutants.
Eshwar, Mahenthiralingam   +2 more
openaire   +2 more sources

Burkholderia cepacia Sepsis Among Neonates

The Indian Journal of Pediatrics, 2014
Burkholderia cepacia is a rare cause of sepsis in newborns and its transmission involves human contact with heavily contaminated medical devices and disinfectants. The authors aimed to determine epidemiology, clinical features, antibiotic sensitivity pattern, complications and outcome of blood culture proven B. cepacia infections in 12 neonates.
Saikat, Patra   +6 more
openaire   +2 more sources

Update on the Burkholderia cepacia complex

Current Opinion in Pulmonary Medicine, 2005
The Burkholderia cepacia complex is comprised of a group of related bacterial species that are capable of causing life-threatening respiratory tract infection in persons with cystic fibrosis. This article reviews advances in our understanding of Burkholderia cepacia complex infection in cystic fibrosis, focusing on the taxonomy, clinical microbiology ...
openaire   +2 more sources

BURKHOLDERIA CEPACIA ENDOPHTHALMITIS

Retina, 2011
To report the clinical presentations, antibiotic sensitivities, and outcomes of Burkholderia cepacia endophthalmitis.Retrospective, consecutive, noncomparative, interventional case series. We reviewed case records of culture-proven B. cepacia endophthalmitis from the endophthalmitis registry between January 2003 and December 2008.
Virender, Sachdeva   +4 more
openaire   +2 more sources

Burkholderia cepacia Complex and Burkholderia gladioli

2010
The PCR assays described herein can be used to reliably determine if an organism belongs to the Burkholderia cepacia complex or Burkholderia gladioli. Further characterisation of the mostly commonly encountered B. cepacia complex species can be achieved using a range of species-specific PCR assays.
openaire   +3 more sources

Survival of Burkholderia cepacia on environmental surfaces

Journal of Hospital Infection, 1996
Burkholderia (Pseudomonas) cepacia is an important pathogen amongst persons with cystic fibrosis (CF), and evidence suggests that transmission of strains within CF clinics contributes to pulmonary colonization of some patients. In order to optimize preventive strategies, the survival of B.
J A, Drabick   +3 more
openaire   +2 more sources

Burkholderia cepacia infection and lung transplantation

Seminars in Respiratory Infections, 2002
Burkholderia cepacia has emerged as an important pathogen in patients with cystic fibrosis (CF) undergoing lung transplantation. Taxonomic analyses have divided B. cepacia into 7 closely related species called genomovars. The prevalence of B. cepacia infection ranges from 2% to 13% in CF patients with genomovar III being most prevalent.
Shahid, Husain, Nina, Singh
openaire   +2 more sources

Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children

Pediatric Infectious Disease Journal, 2020
Background: Burkholderia cepacia complex is an aerobic, non–spore-forming, catalase-positive, nonfermentative, Gram-negative bacterium common in environment. It is a serious pathogen especially for patients with cystic fibrosis (CF).
Yuksek, Saliha Kanik   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy